Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Convertible Debt (2024)

Firefly Neuroscience has reported Convertible Debt over the past 1 years, most recently at $694000.0 for Q4 2024.

  • Quarterly results put Convertible Debt at $694000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $694000.0 (changed N/A YoY), and the annual figure for FY2024 was $694000.0, changed.
  • Convertible Debt for Q4 2024 was $694000.0 at Firefly Neuroscience.
  • Over the last five years, Convertible Debt for AIFF hit a ceiling of $694000.0 in Q4 2024 and a floor of $694000.0 in Q4 2024.